A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer

نویسندگان

چکیده

(Cell Metabolism 30, 1107–1119.e1–e8; December 3, 2019) As a result of an author oversight in the originally published version this article, example image H&E staining for HKB99 group was accidentally sourced from lung section mice harboring HCC827-Luc, instead HCC827ER9-Luc, when Figure 6F assembled. This error does not affect any results or conclusions paper. The authors sincerely apologize confusion and inconvenience that may have caused. A Novel Allosteric Inhibitor Phosphoglycerate Mutase 1 Suppresses Growth Metastasis Non-Small-Cell Lung CancerHuang et al.Cell MetabolismOctober 10, 2019In BriefPGAM1 plays critical role cancer cell metabolism. Huang al. discovered novel PGAM1 inhibitor HKB99, which allosterically blocks structure PGAM1, impacting both its catalytic activity ACTA2 interaction. significantly inhibits NSCLC tumor growth metastasis vivo by PGAM1’s metabolic nonmetabolic function. Full-Text PDF Open Archive

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1.

Lung cancer is still the leading cause of cancer-related deaths worldwide. Identifying new oncogenic drivers and developing efficient inhibitors through molecular targeting approaches are crucial for improving therapies. The aim of this study was to investigate whether targeting fibroblast growth factor receptor 1 (FGFR1) with ponatinib inhibits the cell growth in both established and primary l...

متن کامل

A review of the role of dopamine receptors and novel therapeutic strategies in non-small cell lung cancer (NSCLC)

Lung cancer is a very aggressive and most deadly cancer in both men and women. Lung cancer is divided into two types of small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC is divided into 3 subgroups: adenocarcinoma (AC), squamous cell carcinoma (SqCC) and large cell carcinoma (LCC). Dopamine is involved in controlling motions, cognition, emotions, memory and reward mech...

متن کامل

MACC-1 antibody target therapy suppresses growth and migration of non-small cell lung cancer

Non‑small‑cell lung cancer (NSCLC) accounts for ~80% of human lung cancers that result in mortalities worldwide. Metastasis‑associated in colon cancer‑1 (MACC‑1) has been demonstrated to be significantly expressed in cases of NSCLC and promotes tumor cell migration and metastasis through transactivation of the metastasis‑inducing hepatocyte growth factor/MET proto‑gene, receptor tyrosine kinase...

متن کامل

Glutathione S-transferase mu2 suppresses cancer cell metastasis in non-small cell lung cancer.

Glutathione S-transferase mu2 (GST-M2) is a phase II detoxification enzyme. Low expression of GST-M2 in lung cancers is due to hypermethylation of its promoter. Lung cancer with the GST mu-null genotype is associated with shorter survival. However, a correlation between GST-M2 and important clinical parameters, as well as the migration of GST-M2-defective cells in lung cancer, has not been esta...

متن کامل

SK-216, a Novel Inhibitor of Plasminogen Activator Inhibitor-1, Suppresses Lung Metastasis of Human Osteosarcoma

Lung metastasis constitutes the leading cause of the death in patients with osteosarcoma. We have previously reported that plasminogen activator inhibitor-1 (PAI-1) regulates the invasion and lung metastasis of osteosarcoma cells in a mouse model and as well as in clinical samples. In the present study, we examined the anti-metastatic effect of SK-216, a small compound PAI-1 inhibitor, in human...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Cell Metabolism

سال: 2021

ISSN: ['1550-4131', '1932-7420']

DOI: https://doi.org/10.1016/j.cmet.2020.12.013